economic impact

  1. rvallee

    Healthcare costs and effects of post-COVID-19 condition in Canada 2023 Rafferty et al

    Healthcare costs and effects of post-COVID-19 condition in Canada https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2023-49/issue-10-october-2023/healthcare-costs-effects-post-covid-19-condition-canada.html Abstract...
  2. SNT Gatchaman

    Trajectories of functional limitations, health-related quality of life and societal costs in individuals with long COVID, 2024, Wang+

    Trajectories of functional limitations, health-related quality of life and societal costs in individuals with long COVID: a population-based longitudinal cohort study Jiunn Wang; Henry Goodfellow; Sarah Walker; Ann Blandford; Paul Pfeffer; John R Hurst; David Sunkersing; Katherine Bradbury...
  3. Kalliope

    Aberrations in medically certified sick leave and primary healthcare consultations in Norway in 2023.... - R. White et al, 2024

    Aberrations in medically certified sick leave and primary healthcare consultations in Norway in 2023 compared to pre-COVID-19-pandemic trends Abstract Background Since 2022, Norway has employed a vaccine-only COVID-19 strategy. Primary healthcare in Norway uses International Classification of...
  4. Nightsong

    The public health and economic burden of long COVID in Australia, 2022–24: a modelling study, 2024, Constantino et al.

    Abstract Objective: To estimate the number of people in Australia with long COVID by age group, and the associated medium term productivity and economic losses. Study design: Modelling study: a susceptible–exposed–infected–recovered (SEIR) model to estimate the number of people with long COVID...
  5. SNT Gatchaman

    The association between prolonged SARS-CoV-2 symptoms and work outcomes, 2024, Venkatesh et al.

    The association between prolonged SARS-CoV-2 symptoms and work outcomes Arjun K. Venkatesh; Huihui Yu; Caitlin Malicki; Michael Gottlieb; Joann G. Elmore; Mandy J. Hill; Ahamed H. Idris; Juan Carlos C. Montoy; Kelli N. O’Laughlin; Kristin L. Rising; Kari A. Stephens; Erica S. Spatz; Robert A...
  6. SNT Gatchaman

    Comparative analysis of financial toxicity between SARS-CoV-2 infection and common comorbidities, 2024, Su et al.

    Comparative analysis of financial toxicity between SARS-CoV-2 infection and common comorbidities Han Su; Hilaire J. Thompson; Karl Cristie Figuracion; Mayur Bipin Patel; Dale M. Needham Financial toxicity is common in individuals with COVID-19 and Long COVID. However, the extent of financial...
  7. SNT Gatchaman

    Review Long COVID science, research and policy, 2024, Al-Aly, Davis, McCorkell, Iwasaki, Topol+

    Long COVID science, research and policy Al-Aly, Ziyad; Davis, Hannah; McCorkell, Lisa; Soares, Letícia; Wulf-Hanson, Sarah; Iwasaki, Akiko; Topol, Eric J. Long COVID represents the constellation of post-acute and long-term health effects caused by SARS-CoV-2 infection; it is a complex...
  8. SNT Gatchaman

    Determining the societal value of a prospective drug for ME/CFS in Germany, 2024, Afschin Gandjour

    Determining the societal value of a prospective drug for ME/CFS in Germany Afschin Gandjour BACKGROUND Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) imposes a substantial societal and economic burden. The aim of this study is to ascertain the optimal level of public research and...
  9. M

    Financial Outcome Measure

    I think a financial outcome measure will be important for getting governmental funding support for bigger trials and making a case for future treatment subsidies. So it should be considered an outcome measure of improvement. There are several factors, these are 3 that spring to mind: -...
  10. SNT Gatchaman

    Impact of COVID-19 on Work Loss in the United States- A Retrospective Database Analysis, 2024, Judy et al.

    Impact of COVID-19 on Work Loss in the United States- A Retrospective Database Analysis Jennifer Judy; Alon Yehoshua; Julie Gouveia-Pisano; Richard A. Brook; Nathan L. Kleinman; Alek A. Drnach; Eric M. Rosenberg; Tanya Ghanjanasak; Deborah A. Winter; Feng Dai; Jannette M. Escobar; Heather Sell...
  11. rvallee

    Analyses of the economic costs and impacts of chronic illnesses like ME/CFS and Long Covid

    Several analyses of the estimated costs and economic impacts of chronic illnesses like ME/CFS and Long Covid have been published. They all show a heavy economic burden, amounting in the trillions in economic losses, that probably make the strongest argument to convince governments and...
  12. SNT Gatchaman

    Organization for Economic Cooperation and Development working paper: The impacts of long COVID across OECD countries

    The impacts of long COVID across OECD countries Ana Espinosa Gonzalez and Elina Suzuki Imperial College London, UK OECD, Directorate for Employment, Labour and Social Affairs, Health Division From Key Findings — 3. Long COVID can severely limit people’s ability to undertake basic activities of...
  13. Andy

    New macroeconomic insights on the impacts of Long Covid in the UK

    "Long Covid is now prevalent in the UK population, with the most recent estimates in March 2023 revealing 1.9 million people living with the condition, of which 1.6 million people are working age. With a growing evidence base revealing the impact of Long Covid on health and livelihoods, and...
  14. SNT Gatchaman

    Nature news feature: Long COVID is a double curse in low-income nations — here’s why

    Long COVID is a double curse in low-income nations — here’s why Not only is the prevalence of the condition poorly understood, but it’s also often ignored by physicians and the wider public.
  15. Sly Saint

    Impact of Long COVID on productivity and informal caregiving 2023 Kwon et al

    Abstract Background Around 2 million people in the UK suffer from Long COVID (LC). Of concern is the disease impact on productivity and informal care burden. This study aimed to quantify and value productivity losses and informal care receipt in a sample of LC patients in the UK. Methods The...
  16. Dolphin

    Trial Report The economic burden of myalgic encephalomyelitis/chronic fatigue syndrome in Australia, 2023, Zhao

    https://www.publish.csiro.au/AH/justaccepted/AH23106 Just Accepted This article has been peer reviewed and accepted for publication. It is in production and has not been edited, so may differ from the final published form. The economic burden of myalgic encephalomyelitis/chronic fatigue...
  17. SNT Gatchaman

    Long COVID: Costs for the German economy and health care and pension system, 2023, Gandjour

    Long COVID: Costs for the German economy and health care and pension system Gandjour, Afschin Background Patients with acute COVID-19 can develop persistent symptoms (long/post COVID-19 syndrome). This study aimed to project the economic, health care, and pension costs due to long/post-COVID-19...
  18. Wyva

    Updated ME/CFS prevalence estimates reflecting post-COVID increases and associated economic costs and funding implications, 2022, Mirin, Jason et al

    ABSTRACT In this article, we update our earlier analyses of myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) economic impact and its National Institutes of Health (NIH) funding versus disease burden, taking into account the anticipated new cases of ME/CFS resulting from COVID-19...
  19. Andy

    A model framework for projecting the prevalence and impact of Long-COVID in the UK, 2021, Martin et al

    Abstract The objective of this paper is to model lost Quality Adjusted Life Years (QALYs) from symptoms arising from COVID-19 disease in the UK population, including symptoms of ‘long-COVID’. The scope includes QALYs lost to symptoms, but not deaths, due to acute COVID-19 and long-COVID. The...
  20. Wyva

    The Conversation: Why governments will have to consider the costs of long COVID when easing pandemic restrictions

    Author: Richard Meade Research Fellow in Economics, and in Social Sciences & Public Policy, Auckland University of Technology He also used to suffer from ME/CFS and compares the two in the article as well. "The social costs of long COVID should not be underestimated. For example, suppose an...
Back
Top Bottom